Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found […]
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a probiotic-based therapeutic that synergistically restores intestinal redox and microbiota homeostasis. This therapeutic effectively relieved inflammation and reduced colonic […]
The average human gut contains roughly 100 trillion microbes, many of which are constantly competing for limited resources. “It’s such a harsh environment,” says César de la Fuente, Presidential Assistant Professor in Bioengineering and in Chemical […]
Ancilia Biosciences, Inc., (Ancilia Bio), a biotechnology company harnessing the natural power of CRISPR to create bacterial therapies and products with immunity against destructive viruses, today announced the closing of a $4.2 million financing. The […]
Scientists at University of California San Diego have discovered another factor that affects the composition of the gut microbiome: time of day. In fact, the scientists have found that time of day is such an […]
Microbes that are used for health, agricultural, or other applications need to be able to withstand extreme conditions, and ideally the manufacturing processes used to make tablets for long-term storage. MIT researchers have now developed […]
SNIPR BIOME receives funding from the Bill & Melinda Gates Foundation to accelerate the development of SNIPR Biome’s microbial gene therapy platform to improve Environmental Enteric Dysfunction (EED) in pregnant women from low- and middle-income […]
As the self-care movement drives consumers toward proactive health choices, the hunt for holistic well-being will stimulate innovations in the microbiome space. Scientific communities and consumers alike recognize the gut microbiome as an organ with […]
In a newly published study, Enbiosis’ AI-designed personalized diet was shown to significantly improve patients’ IBS symptoms. The results of this study provide further clinical evidence of Enbiosis’ expertise in AI-powered precision nutrition following their […]
Current treatments for Bacterial Vaginosis, a condition caused by a disturbed vaginal microbiota resulting in certain bacteria becoming overgrown, comprise of antibiotics – tablets, gels, or creams. Antibiotics work by killing the overgrown bacteria to […]
BioMe, a prominent player in the field of Live Biotherapeutic Products (LBPs), has recently made significant strides with its latest drug development candidate, BM109, aimed at treating Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) […]